The Truth Social post landed at 11:46 AM on Saturday, January 18. By noon, Novo Nordisk’s stock was dropping. By Monday morning, eight European countries faced new tariffs, pharmaceutical supply chains were in question, and PR teams across the industry were scrambling to explain what this meant for drug prices, manufacturing plans, and patient access. […]
Why Your Biotech Company’s Media Monitoring Strategy Needs a Reality Check
Picture this: It’s 7 AM, and your phone buzzes with an urgent message from your CEO. A clinical trial story just broke in European media, your stock price is already moving, and investors are asking questions. But here’s the kicker—your media monitoring system missed it entirely because the coverage started in German biotech publications that […]


